Literature DB >> 15786727

Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals.

Alexander V Panov1, Serena Lund, J Timothy Greenamyre.   

Abstract

Huntington's disease (HD) is associated with expansion of polyglutamine tract in a protein named huntingtin (htt) that is expressed in virtually all body tissues. Thus mutated htt (HD-htt) might affect all organs, although clinical manifestations of HD are associated with selective loss of corticostriatal neurons of the brain. In this work we studied how HD-htt affects mitochondria in human peripheral blood cells. We compared various functions of mitochondria isolated from cultured lymphoblastoid cells derived from three HD patients with juvenile onset of the disease (HD-LBM) and three age-matched control (C-LBM) individuals. Respiratory parameters in different metabolic states, with succinate and glutamate plus malate were the same for all control and HD cell lines. State 4 membrane potential in HD-LBM was slightly lower than in C-LBM. The calcium retention capacity (CRC) of mitochondria was estimated using simultaneously several methods to register permeability transition (PT). We found that LBM do not undergo swelling upon Ca2+-induced PT, and do not increase CRC in the presence of ADP + oligomycin. Although each cell line had different CRC values, qualitatively PT was different in C-LBM and HD-LBM. With C-LBM cyclosporin A (CsA) increased CRC significantly, while with HD-LBM CsA was ineffective. In C-LBM depolarization of mitochondria and a large pore opening (PT) always occurred simultaneously. In HD-LBM depolarization occurred at 20-50% lower Ca2+ loads than PT. We suggest that HD-htt promotes low H+ conductance of the mitochondria by interacting with proteins at the contacts sites without directly promoting PT or hampering mitochondrial oxidative phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786727     DOI: 10.1007/s11010-005-3454-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  47 in total

1.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.

Authors:  S Shimizu; M Narita; Y Tsujimoto
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

2.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Authors:  S J Tabrizi; M W Cleeter; J Xuereb; J W Taanman; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

3.  Mitochondrial function in Huntington's disease: clues for pathogenesis and prospects for treatment.

Authors:  A H Schapira
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

4.  Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane.

Authors:  Nickolay Brustovetsky; Tatiana Brustovetsky; Ronald Jemmerson; Janet M Dubinsky
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

5.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Mitochondrial depolarization is not required for neuronal apoptosis.

Authors:  A J Krohn; T Wahlbrink; J H Prehn
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 7.  Bioenergetics and glutamate excitotoxicity.

Authors:  J G Greene; J T Greenamyre
Journal:  Prog Neurobiol       Date:  1996-04       Impact factor: 11.685

Review 8.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

9.  Regulation of the uncoupling protein in brown adipose tissue.

Authors:  K F LaNoue; T Strzelecki; D Strzelecka; C Koch
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

10.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  31 in total

1.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Inhibitors of metabolism rescue cell death in Huntington's disease models.

Authors:  Hemant Varma; Richard Cheng; Cindy Voisine; Anne C Hart; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

Review 3.  Mitochondrial medicine for aging and neurodegenerative diseases.

Authors:  P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2008-06-20       Impact factor: 3.843

4.  Rapamycin increases oxidative metabolism and enhances metabolic flexibility in human cardiac fibroblasts.

Authors:  Timothy Nacarelli; Ashley Azar; Oya Altinok; Zulfiya Orynbayeva; Christian Sell
Journal:  Geroscience       Date:  2018-06-21       Impact factor: 7.713

5.  Effect of solanine on the membrane potential of mitochondria in HepG2 cells and [Ca2+]i in the cells.

Authors:  Shi-Yong Gao; Qiu-Juan Wang; Yu-Bin Ji
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

6.  Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease.

Authors:  Maria Manczak; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

Review 7.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Mitochondrial calcium function and dysfunction in the central nervous system.

Authors:  David G Nicholls
Journal:  Biochim Biophys Acta       Date:  2009-03-17

9.  Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.

Authors:  E Shen; Yanwen Li; Ying Li; Limei Shan; Huaqing Zhu; Qingping Feng; J Malcolm O Arnold; Tianqing Peng
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

Review 10.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.